Tandem Diabetes Care TNDM Payments to Acquire Short-Term Investments
Payments to Acquire Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's payments to acquire short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's payments to acquire short-term investments?
- Tandem Diabetes Care (TNDM) reported payments to acquire short-term investments of $216.13M in Q1 2026.
- How has Tandem Diabetes Care's payments to acquire short-term investments changed year-over-year?
- Tandem Diabetes Care's payments to acquire short-term investments increased by 2187.1% year-over-year, from $9.45M to $216.13M.
- What is the long-term trend for Tandem Diabetes Care's payments to acquire short-term investments?
- Over 4 years (2021 to 2025), Tandem Diabetes Care's payments to acquire short-term investments has grown at a -41.5% compound annual growth rate (CAGR), from $733.39M to $85.66M.